The antihypertensive effect of peptides: A novel alternative to drugs?

Peptides

Volumn 29, Issue 6, 2008, Pages 1062-1071

  Hong, Fang ^a   Ming, Luo ^a   Yi, Sheng ^a   Zhanxia, Li ^a   Yongquan, Wu ^a   Chi, Liu ^a  

^a TONGJI UNIVERSITY   (China)

Author keywords

Bioactive peptides; Hypertension; Renin angiotensin system

Indexed keywords

ALANYLTYROSYLPHENYLALANYLTYROSYLPROLYLGLUTAMIC ACID; ALANYLTYROSYLPROLYLSERINE; ALANYLVALYLPROLYLTYROSYLPROLYLGLUTAMINE; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN I; ARGINYLASPARTYLMETHIONYLPROLYLISOLEUCYLGLUTAMINYLALANYLPHENYLALANINE; ARGINYLPROLYLLYSYLHISTIDYLPROLYLISOLEUCINE; ARGINYLPROLYLLYSYLHISTIDYLPROLYLISOLEUCYLLYSYLHISTIDYLGLUTAMINE; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUTAMINYLSERYLLEUCYLTHREONYLLEUCINE; GLYCYLALANYLTRYPTOPHYLTYROSYLTYROSYLVALYLPROLYLLEUCINE; GLYCYLSERYLGLUTAMYLASPARAGINE; GLYCYLSERYLGLUTAMYLASPARAGINYLSERYLGLUTAMYLLYSINE; LEUCYLTRYPTOPHAN; LYSYLALANYLVALYLPROLYLTYROSYLPROLYLGLUTAMINE; LYSYLTYROSYLPROLYLVALYLGLUTAMINYLPROLYLPHENYLALANYLTHREONYL GLUTAMYLSERYLGLUTAMINYLSERYLLEUCYLTHREONYLLEUCINE; MILK PROTEIN; OVOKININ[2-7]; PEPTIDE; PHENYLALANYLPHENYLALANYLVALYLALANYLPROLINE; PHENYLALANYLVALYLALANYLPROLINE; PHENYLALANYLVALYLALANYLPROLYLPHENYLALANYLPROLYLGLUTAMINYLVALINE; PROLYLLEUCYLTRYPTOPHAN; SERYLLYSYLVALYLLEUCYLPROLYLVALYLPROLYLGLUTAMIC ACID; THREONYLTHREONYLMETHIONYLPROLYLLEUCYLTRYPTOPHAN; TYROSYLLYSYLVALYLPROLYLGLUTAMINYLLEUCINE; TYROSYLPROLINE; UNINDEXED DRUG; VALYLALANYLPROLINE;

BLOOD PRESSURE; CARDIOVASCULAR SYSTEM; DRUG BIOAVAILABILITY; EGG; FISH; FOOD; HUMAN; HYPERTENSION; IMMUNIZATION; NONHUMAN; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ANTIHYPERTENSIVE AGENTS; HUMANS; HYPERTENSION; PEPTIDE FRAGMENTS; PHARMACEUTICAL PREPARATIONS; RECEPTORS, ANGIOTENSIN; RENIN-ANGIOTENSIN SYSTEM;

EID: 43049107998     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2008.02.005     Document Type: Review

References (105)

1. Abubakar A., Tadao S., Kitazawa H., Kawai Y., and Itoh T. Structural analysis of new antihypertensive peptides derived from cheese whey protein by proteinase K digestion. J Dairy Sci 81 (1998) 3131-3138
2. Addeo F., Chianes L., Salzano A., Sacchi R., Cappuccio U., Ferranti P., et al. Characterisation of the 12% trichloroacetic acid insoluble oligopeptides of Parmigiano-Reggiano cheese. J Dairy Res 59 (1992) 401-411
3. Aihara K., Kajimoto O., Hirata H., Takahashi R., and Nakamura Y. Effect of powdered fermented milk with Lactobacillus helveticus on subjects with high-normal blood pressure or mild hypertension. J Am Coll Nutr 24 (2005) 257-265
4. Allen C., Palta M., LeCaire T., Huang G.H., Brazy P., and D'Alessio D. Does increase in blood pressure predict increase in urinary albumin excretion rate in the first 9 years of type 1 diabetes?. Ann Epidemiol 12 (2002) 498-505
5. Brown N.J., and Vaughan D.E. Angiotensin-converting enzyme inhibitors. Circulation 97 (1998) 1411-1420
6. Cha M., Park J.R., and Yoon K.Y. Purification and characterization of an alkaline serine protease producing angiotensin I-converting enzyme inhibitory peptide from Bacillus sp. SS103. J Med Food 8 (2005) 462-468
7. Cheung H.S., Feng-Lai W., Ondetti M.A., Sabo E.F., and Cushman D.W. Binding of peptide substrates and inhibitors of angiotensin-converting-enzyme. J Biol Chem 255 (1980) 401-407
8. Collins R., Peto R., MacMahon S., Herbert P., Fiebach N.H., Eberlein K.A., et al. Blood pressure, stroke, and coronary heart disease. Part 2. Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 335 (1990) 827-838
9. Conlin P.R., Chow D., Miller E.R., Svetkey L.P., Lin P.H., Harsha D.W., et al. The effect of dietary patterns on blood pressure control in hypertensive patients: results from the Dietary Approaches to Stop Hypertension (DASH) trial. Am J Hyperten 13 (2001) 949-955
10. Costerousse O., Jaspard E., Wei L., Corvol P., and Alhenc-Gelas F. The angiotensin I-converting enzyme (kininase II): molecular organization and regulation of its expression in humans. J Cardiovasc Pharmacol 20 (1992) S10-S15
11. Cushman D.W., and Cheung H.S. Concentrations of angiotensin-converting enzyme in tissues of the rat. Biochim Biophys Acta 250 (1971) 261-265
12. Dimsdale J.E., Kolterman O., Koda J., and Nelesen R. Effect of race and hypertension on plasma amylin concentrations. Hypertension 27 (1996) 1273-1276
13. Dostal D.E., and Baker K.M. The cardiac renin-angiotensin system: conceptual, or a regulator of cardiac function?. Circ Res 85 (1999) 643-650
14. Downham M.R., Auton T.R., Rosu l A., Sharp H.L., Sjostrom L., Rushton A., et al. Evaluation of two carrier protein-angiotensin I conjugate vaccines to assess their future potential to control high blood pressure (hypertension) in man. Br J Clin Pharmacol 56 (2003) 505-512
15. Dubay C., Vincent M., Samani N.J., Hilbert P., Kaiser M.A., Beressi J.P., et al. Genetic determinants of diastolic and pulse pressure map to different loci in Lyon hypertensive rats. Nat Genet 3 (1993) 354-357
16. Dézsi L. Fibrinolytic actions of ACE inhibitors: a significant plus beyond antihypertensive therapeutic effects. Cardiovasc Res 47 (2000) 642-644
17. Elbl G., and Wagner H. A new method for the in vitro screening of inhibitors of angiotensin-converting enzyme (ACE), using the chromophore- and fluorophore-labelled substrate, dansyltriglycine. Planta Med 57 (1991) 137-141
18. Farias S.L., Sabatini R.A., Sampaio T.C., Hirata I.Y., Cezari M.H., Juliano M.A., et al. Angiotensin I-converting enzyme inhibitor peptides derived from the endostatin-containing NC1 fragment of human collagen XVIII. Biol Chem 387 (2006) 611-616
19. Fernandez J.H., Neshich G., and Camargo A.C. Using bradykinin-potentiating peptide structures to develop new antihypertensive drugs. Genet Mol Res 3 (2004) 554-563
20. FitzGerald R.J., and Meisel H. Milk protein-derived peptide inhibitors of angiotensin-I-converting enzyme. Br J Nutr 84 (2000) S33-S37
21. FitzGerald R.J., Murray B.A., and Walsh D.J. Hypotensive peptides from milk proteins. J Nutr 134 (2004) 980S-988S
22. Frantz S. Antihypertensive treatments-ALLHATs off to the golden oldie. Nat Rev Drug Discov 2 (2003) 91
23. Fu M.L., Leung P.S., Wallukat G., Bergstrom G., Fu H., Schulze W., et al. Agonist-like activity of antibodies to angiotensin II receptor subtype 1 (AT1) from rats immunized with AT1 receptor peptide. Blood Press 8 (1999) 317-324
24. Fuglsang A., Nilsson D., and Nyborg N. Cardiovascular effects of fermented milk containing angiotensin-converting enzyme inhibitors evaluated in permanently cathereterized spontaneously hypertensive rats. Appl Environ Microbiol l68 (2002) 3566-3569
25. Fujita H., and Yoshikawa M. LKPNM: a prodrug-type ACE-inhibitory peptide derived from fish protein. Immunopharmacology 44 (1999) 123-127
26. Furushiro M., Hashimoto S., Hamura M., and Yokokura T. Mechanism for the antihypertensive effect of a polysaccharide-glycopeptide complex from Lactobacillus casei in spontaneously hypertensive rats (SHR). Biosci Biotechnol Biochem 57 (1993) 978-981
27. Geerlings A., Villar I.C., Hidalgo Z.F., Sanchez M., Vera R., Zafra G.A., et al. Identification and characterization of novel angiotensin-converting enzyme inhibitors obtained from goat milk. J Dairy Sci 89 (2006) 3326-3335
28. Gobbetti M., Ferranti P., Smacchi E., Goffredi F., and Addeo F. Production of angiotensin-I-converting enzyme inhibitory peptides in fermented milks started by Lactobacillus delbruekii subsp. bulgaricus SS1 and Lactococcus lactis subsp. cremoris FT4. Appl Environ Microbiol 66 (2000) 3898-3904
29. Harsha D.W., Lin P.H., Obarzanek E., Karanja N.M., Moore T.J., and Caballero B. Dietary approaches to stop hypertension: a summary of study results. J Am Diet Assoc 99 (1999) S35-S39
30. Hata Y., Yamamoto M., Ohni M., Nakajima K., Nakamura Y., and Takano T. A placebo-controlled study of the effect of sour milk on blood pressure in hypertensive subjects. Am J Clin Nutr 64 (1996) 767-771
31. He G.Q., Xuan G.D., Ruan H., Chen Q.H., and Xu Y. Optimization of angiotensin I-converting enzyme (ACE) inhibition by rice dregs hydrolysates using response surface methodology. J Zhejiang Univ Sci B 6 (2005) 508-513
32. Hyoung L.D., Ho K.J., Sik P.J., Jun C.Y., and Soo L.J. Isolation and characterization of a novel angiotensin I-converting enzyme inhibitory peptide derived from the edible mushroom Tricholoma giganteum. Peptides 25 (2004) 621-627
33. Ichimura T., Hu J., Aita D.Q., and Maruyama S. Angiotensin I-converting enzyme inhibitory activity and insulin secretion stimulative activity of fermented fish sauce. J Biosci Bioeng 96 (2003) 496-499
34. Igarashi K., Yoshioka K., Mizutani K., Miyakoshi M., Murakami T., and Akizawa T. Blood pressure-depressing activity of a peptide derived from silkworm fibroin in spontaneously hypertensive rats. Biosci Biotechnol Biochem 70 (2006) 517-520
35. Jaspard E., Costerousse O., Wei L., Corvol P., and Alhenc-Gelas F. The angiotensin I-converting enzyme (kininase II): molecular and regulatory aspects. Agents Actions Suppl 38 (1992) 349-358
36. Je J.Y., Park P.J., Kwon J.Y., and Kim S.K. A novel angiotensin I converting enzyme inhibitory peptide from Alaska pollack (Theragra chalcogramma) frame protein hydrolysate. J Agric Food Chem 52 (2004) 7842-7845
37. Je J.Y., Park P.J., Byun H.G., Jung W.K., and Kim S.K. Angiotensin I converting enzyme (ACE) inhibitory peptide derived from the sauce of fermented blue mussel, Mytilus edulis. Bioresour Technol 96 (2005) 1624-1629
38. Kitts D.D., and Weiler K. Bioactive proteins and peptides from food sources. Applications of bioprocesses used in isolation and recovery. Curr Pharm Des 9 (2003) 1309-1323
39. Labinjoh C., Newby D.E., Dawson P., Johnston N.R., Ludlam C.A., Boon N.A., et al. Fibrinolytic actions of intra-arterial angiotensin II and bradykinin in vivo in man. Cardiovasc Res 47 (2000) 707-714
40. Lavoie J.L., and Sigmund C.D. Minireview: overview of the renin-angiotensin system-an endocrine and paracrine system. Endocrinology 144 (2003) 2179-2183
41. Leclerc P.L., Gauthier S.F., Bachelard H., Santure M., and Roy D. Antihypertensive activity of casein-enriched milk fermented by Lactobacillus helveticus. Int Dairy J 12 (2002) 995-1004
42. Li G.H., Wan J.Z., Le G.W., and Shi Y.H. Novel angiotensin I-converting enzyme inhibitory peptides isolated from alcalase hydrolysate of mung bean protein. J Pept Sci 12 (2006) 509-514
43. Lo W.M., and Li-Chan E.C. Angiotensin I converting enzyme inhibitory peptides from in vitro pepsin-pancreatin digestion of soy protein. J Agric Food Chem 53 (2005) 3369-3376
44. Ma M.S., Bae I.Y., Lee H.G., and Yang C.B. Purification and identification of angiotensin I-converting enzyme inhibitory peptide from buckwheat (Fagopyrum esculentum Moench). Food Chem 96 (2005) 36-42
45. Maeno M., Yamamoto N., and Takano T. Identification of an antihypertensive peptide from casein hydrolysate produced by a proteinase from Lactobacillus helveticus CP790. J Dairy Sci 73 (1996) 1316-1321
46. MacMahon S., Peto R., Cutler J., Collins R., Sorlie P., Neaton J., et al. Blood pressure, stroke, and coronary heart disease. Part 1. Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 335 (1990) 765-774
47. Mallikarjun Gouda K.G., Gowda L.R., Rao A.G., Rao A.G., and Prakash V. Angiotensin I-converting enzyme inhibitory peptide derived from glycinin, the 11S globulin of soybean (Glycine max). J Agric Food Chem 54 (2006) 4568-4573
48. Maruyama S., Mitachi H., Tanaka H., Tomizuka N., and Suzuki H. Studies on the active site and antihypertensive activity of angiotensin I-converting enzyme inhibitors derived from casein. Agric Biol Chem 51 (1987) 1581-1586
49. Matoba S., Tatsumi T., Keira N., Kawahara A., Akashi K., Kobara M., et al. Cardioprotective effect of angiotensin-converting enzyme inhibition against hypoxia/reoxygenation injury in cultured rat cardiac myocytes. Circulation 99 (1999) 817-822
50. Mazen K., Walmor C., De M., and George W.B. Working outside the system: an update on the unconventional behavior of the renin-angiotensin system components. Int J Biochem Cell Biol 37 (2005) 1357-1367
51. McKinley M.J., Albiston A.L., Allen A.M., Mathai M.L., May C.N., McAllen R.M., et al. The brain renin-angiotensin system: location and physiological roles. Int J Biochem Cell Biol 1430 (2003) 1-18
52. Meisel H. Biochemical properties of regulatory peptides derived from milk proteins. Biopolymers 43 (1997) 119-128
53. Meisel H. Multifunctional peptides encrypted in milk proteins. Biofactors 21 (2004) 55-61
54. Meisel H. Casokinins as inhibitors of angiotensin-I-converting enzyme. In: Sawatski G., and Renner B. (Eds). New perspectives in infant nutrition (1993) 153-159
55. Meisel H., and Bockelmann W. Bioactive peptides encrypted in milk proteins: proteolytic activation and thropho-functional properties. Ant van Leeuwen 76 (1999) 207-215
56. Meisel H., Goepfert A., and Guenther S. ACE-inhibitory activities in milk products. Milchwiss 52 (1997) 307-311
57. Meisel H., and FitzGerald R.J. Opioid peptides encrypted in intact milk protein sequences. Br J Nutr 84 (2000) S27-S31
58. Messerli F.H., Weber M.A., and Brunner H.R. Angiotensin II receptor inhibition. A new therapeutic principle. Arch Intern Med 156 (1996) 1957-1965
59. Michel J.B. Renin-angiotensin vaccine: old story, new project 'efficacy versus safety'. Clin Sci (Lond) 107 (2004) 145-147
60. Michel J.B., Huang H.M., Guettier C., Gonzalez M.F., Baussant T., Murakami T., et al. Renin immunization and angiotensin converting enzyme inhibition in the normotensive marmoset. J Hypertens Suppl 7 (1989) S218-S219
61. Miguel M., and Aleixandre A. Antihypertensive peptides derived from egg proteins. J Nutr 136 (2006) 1457-1460
62. Miguel M., Recio I., Ramos M., Delgado M.A., and Aleixandre M.A. Antihypertensive effect of peptides obtained from Enterococcus faecalis-fermented milk in rats. J Dairy Sci 89 (2006) 3352-3359
63. Miguel M., Recio I., Gomez-Ruiz J.A., Ramos M., and Lopez-Fandino R. Angiotensin I-converting enzyme inhibitory activity of peptides derived from egg white proteins by enzymatic hydrolysis. J Food Prot 67 (2004) 1914-1920
64. Mito K., Fujii M., Matsumura N., Shimizu T., Sugano S., and Karaki H. Antihypertensive effect of angiotensin I-converting enzyme inhibitory peptides derived from hemoglobin. Eur J Pharmacol 304 (1996) 93-98
65. Moskowitz D.W. Is "somatic" angiotensin I-converting enzyme a mechanosensor?. Diabetes Technol Ther 4 (2002) 841-858
66. Motoi H., and Kodama T. Isolation and characterization of angiotensin I-converting enzyme inhibitory peptides from wheat gliadin hydrolysate. Nahrung 47 (2003) 354-358
67. Nakamura Y., Masuda O., and Takano T. Decrease of tissue angiotensin I-converting enzyme activity upon feeding sour milk in spontaneously hypertensive rats. Biosci Biotechnol Biochem 60 (1996) 488
68. Nakajima M., Yamato S., Wakabayashi H., and Shimada K. High-performance liquid chromatographic determination of cholesterol and cholestanol in human serum by precolumn derivatization with 2-[2-(isocyanate)ethyl]-3-methyl-1,4-naphthoquinone combined with platinum catalyst reduction and electrochemical detection. Biol Pharm Bull 18 (1995) 1762-1764
69. Nakano D., Ogura K., Miyakoshi M., Ishii F., Kawanishi H., Kurumazuka D., et al. Antihypertensive effect of angiotensin I-converting enzyme inhibitory peptides from a sesame protein hydrolysate in spontaneously hypertensive rats. Biosci Biotechnol Biochem 70 (2006) 1118-1126
70. National Heart, Lung and Blood Institute. The seventh report of the joint national committee on prevention, detection, evaluation and treatment of high blood pressure. Publication No. 03-5233. Bethesda, MD: National Institute of Health; 2003.
71. Neutel J.M., Smith D.H., and Weber M.A. Is high blood pressure a late manifestation of the hypertension syndrome?. Am J Hypertens 12 (1999) 215S-223S
72. Nimmagudda R. New bioactive peptides for the nutritional industry. Oral presentation at: Supply Side West Trade Show and Conference 2002 Las Vegas, NV December 4th to 6th.
73. Okitsu M., Morita A., Kakitani M., Okada M., and Yokogoshi H. Inhibition of the endothelin-converting enzyme by pepsin digests of food proteins. Biosci Biotechnol Biochem 59 (1995) 325-326
74. Ondetti M.A., and Cushman D.W. Enzymes of the renin-angiotensin system and their inhibitors. Annu Rev Biochem 51 (1982) 283-308
75. Ondetti M.A., Rubin B., and Cushman D.W. Design of specific inhibitors of angiotensin-converting enzyme: new class of orally active antihypertensive agents. Science 4288 (1977) 441-444
76. Pachori A.S., Huentelman M.J., Francis S.C., Gelband C.H., Katovich M.J., and Raizada M.K. The future of hypertension therapy: sense, antisense, or nonsense?. Hypertension 37 (2001) 357-364
77. Pihlanto-Leppälä A., Rokka T., and Korhonen H. Angiotensin I converting enzyme inhibitory peptides derived from bovine milk proteins. Int Dairy J 8 (1998) 325-331
78. ® 1). Cardiovasc Drugs Ther 16 (2002) 68
79. Riordan J.F. Angiotensin-I-converting enzyme and its relative. Genome Biol 4 (2003) 225 [Epub July 25, 2003]
80. Ryhänen E.L., Pihlanto-Leppälä A., and Pahkala E. A new type of ripened, low-fat cheese with bioactive properties. Int Dairy J 11 (2001) 441-447
81. Saiga A., Okumura T., Makihara T., Katsuda S., Morimatsu F., and Nishimura T. Action mechanism of an angiotensin I-converting enzyme inhibitory peptide derived from chicken breast muscle. J Agric Food Chem 54 (2006) 942-945
82. Saito T., Nakamura T., Kitazawa H., Kawai Y., and Itoh T. Isolation and structural analysis of antihypertensive peptides that exist naturally in Gouda cheese. J Dairy Sci 83 (2000) 1434-1440
83. Sano J., Ohki K., Higuchi T., Aihara K., Mizuno S., Kajimoto O., et al. Effect of casein hydrolysate, prepared with protease derived from Aspergillus oryzae, on subjects with high-normal blood pressure or mild hypertension. J Med Food 8 (2005) 423-430
84. Sawada H., Furushiro M., Hirai K., Motoike M., Watanabe T., and Yokokura T. Purification and characterization of an antihypertensive compound from Lactobacillus casei. Agric Biol Chem 54 (1990) 3211-3219
85. Schlothauer RC, Schollum LM, Singh AM, Reid JR. Bioactive whey protein hydrolysate (WO 99/65326).
86. Sekiya W.S., Kobayashi Y., Kita E., Imamura Y., and Toyama S. Antihypertensive effects of tryptic hydrolysate of casein on normotensive and hypertensive volunteers (in Japanese). J Jpn Soc Nutr Food Sci 45 (1992) 513-517
87. Seppo L., Jauhiainen T., Poussa T., and Korpela R. A fermented milk high in bioactive peptides has a blood pressure-lowering effect in hypertensive subjects. Am J Clin Nutr 77 (2003) 326-330
88. Seppo L., Kerojoki O., Suomalainen T., and Korpela R. The effect of a Lactobacillus helveticus LBK-16 H fermented milk on hypertension-a pilot study on humans. Milchwissen 57 (2002) 124-127
89. Sipola M., Finckenberg P., Vapaatalo H., Pihlanto-Leppala A., Korhonen H., Korpela R., et al. Alpha-lactorphin and beta-lactorphin improve arterial function in spontaneously hypertensive rats. Life Sci 71 (2002) 1245-1253
90. Sipola M., Finckenberg P., Korpela R., Vapaatalo H., and Nurminen M.L. Effect of long-term intake of milk products on blood pressure in hypertensive rats. J Dairy Res 69 (2002) 103-111
91. Skirgello O.E., Balyasnikova I.V., Binevski P.V., Sun Z.L., Baskin I.I., Palyulin V.A., et al. Inhibitory antibodies to human angiotensin-converting enzyme: fine epitope mapping and mechanism of action. Biochemistry 45 (2006) 4831-4847
92. Stamler J. Dietary sodium and blood pressure. JAMA 276 (1996) 1467 [author reply 1469-70]
93. Stamler J., Elliott P., Kesteloot H., Nichols R., Claeys G., Dyer A.R., et al. Inverse relation of dietary protein markers with blood pressure. Findings for 10,020 men and women in the INTERSALT Study. INTERSALT Cooperative Research Group. INTERnational study of SALT and blood pressure. Circulation 94 (1996) 1629-1634
94. Stepaniak L., Jedrychowski L., Wroblewska B., and Sørhaug T. Immunoreactivity and inhibition of angiotensin I converting enzyme and lactococcal oligopeptidase by peptides from cheese. Ital J Food Sci 13 (2001) 373-381
95. Suetsuna K. Purification and identification of angiotensin I-converting enzyme inhibitors from the red alga Porphyra yezoensis. J Mar Biotechnol 6 (1998) 163-167
96. Suetsuna K., and Chen J.R. Identification of antihypertensive peptides from peptic digest of two microalgae, Chlorella vulgaris and Spirulina platensis. Mar Biotechnol (NY) 3 (2001) 305-309
97. Vermeirssen V., Van J.C., and Verstraete W. Bioavailability of angiotensin I converting enzyme inhibitory peptides. Br J Nutr 92 (2004) 357-366
98. Vermeirssen V., Van J.C., Devos L., and Verstraete W. Release of angiotensin I converting enzyme (ACE) inhibitory activity during in vitro gastrointestinal digestion: from batch experiment to semicontinuous model. J Agric Food Chem 51 (2003) 5680-5687
99. World Health Organisation. Diet, nutrition and the prevention of chronic disease. A Report of a Joint World Health Organisation/Food and Agriculture Organisation Expert Consultation. Geneva: WHO; 2003.
100. Wu J., Yuan L., and Aluko R.E. Restriction of the in vitro formation of angiotensin II by leucinyl-arginyl-tryptophan, a novel peptide with potent angiotensin I-converting enzyme inhibitory activity. Biosci Biotechnol Biochem 70 (2006) 1277-1280
101. Wyvratt M.J., and Patchett A.A. Recent developments in the design of angiotensin-converting enzyme inhibitors. Med Res Rev 5 (1985) 483-531
102. Yamamoto N., Maeno M., and Takano T. Purification and characterization of an antihypertensive peptide from a yogurt-like product fermented by Lactobacillus helveticus CPN4. J Dairy Sci 82 (1999) 1388-1393
103. Yamamoto K., Haneda K., Iguchi R., Inazu T., Mizuno M., Takegawa K., et al. Chemo-enzymatic synthesis of a calcitonin derivative containing a high-mannose type oligosaccharide by endo-beta-N-acetylglucosaminidase from Arthrobacter protophormiae. J Biosci Bioeng 87 (1999) 175-179
104. Yoshiji H., Kuriyama S., Kawata M., Yoshii J., Ikenaka Y., Noguchi R., et al. The angiotensin-I-converting enzyme inhibitor perindopril suppresses tumor growth and angiogenesis: possible role of the vascular endothelial growth factor. Clin Cancer Res 7 (2001) 1073-1078
105. Yu Y., Hu J., Miyaguchi Y., Bai X., Du Y., and Lin B. Isolation and characterization of angiotensin I-converting enzyme inhibitory peptides derived from porcine hemoglobin. Peptides 27 (2006) 2950-2956